New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
CAMP4 Therapeutics Corporation (CAMP) vs Prelude Therapeutics Incorporated (PRLD)
- CAMP4 Therapeutics Corporation CAMP 3.79 −5.25%
- Prelude Therapeutics Incorporated PRLD 3.23 −0.92%
CAMP4 Therapeutics Corporation and Prelude Therapeutics Incorporated are both Biotechnology companies. CAMP4 Therapeutics Corporation and Prelude Therapeutics Incorporated are of similar size ($260.5M and $251.0M). Prelude Therapeutics Incorporated has the higher net margin (−247.1% vs −2,276.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Prelude Therapeutics Incorporated leads on 10 and CAMP4 Therapeutics Corporation on 2.
Valuation
Profitability
| Metric | CAMP | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (1,001.05%) | (283.92%) | 0.00% |
| Net margin | (2,276.33%) | (247.12%) | 0.00% |
| Free cash flow margin | — | (129.68%) | 0.00% |
| Return on equity | (146.12%) | (58.36%) | (51.58%) |
| Return on assets | (109.89%) | (39.45%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack